Creative Medical Technology Holdings earnings were -$5.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CELZ earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.9M, up 78.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CELZ reported annual earnings of -$5.5M, with 3.9% growth. The next CELZ earnings date is May 8, 2025.
Creative Medical Technology Holdings Earnings Reports & History FAQ
What were Creative Medical Technology Holdings's earnings last quarter?
On CELZ's earnings call on Invalid Date, Creative Medical Technology Holdings (NASDAQ: CELZ) reported Q4 2024 earnings per share (EPS) of -$1.12, up 7.44% year over year. Total CELZ earnings for the quarter were -$1.85 million. In the same quarter last year, Creative Medical Technology Holdings's earnings per share (EPS) was -$1.21.
When does Creative Medical Technology Holdings report earnings?
The next CELZ earnings call is Invalid Date. Add CELZ to your watchlist to be reminded of Creative Medical Technology Holdings's next earnings date.
What was CELZ's earnings growth in the past year?
As of Creative Medical Technology Holdings's earnings date in Invalid Date, Creative Medical Technology Holdings's earnings has grown year over year. CELZ earnings in the past year totalled -$5.49 million.
Is Creative Medical Technology Holdings profitable or losing money?
As of the last Creative Medical Technology Holdings earnings report, Creative Medical Technology Holdings is currently losing money. Creative Medical Technology Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$5.49 million, a 3.91% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.